{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:56:07Z","timestamp":1791953767219,"version":"4.3.4"},"reference-count":22,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,1,31]]},"DOI":"10.1536\/ihj.18-125","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T22:24:47Z","timestamp":1542666287000},"page":"226-230","source":"Crossref","is-referenced-by-count":5,"title":["Endovascular Therapy Using Diluted Contrast Medium for Critical Limb Ischemia in a Patient with Chronic Kidney Disease"],"prefix":"10.1536","volume":"60","author":[{"given":"Naoki","family":"Hayakawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Asahi General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Asahi General Hospital"},{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Ohki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Asahi General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syunichi","family":"Kushida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Asahi General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Asahi General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Romano G, Briguori C, Quintavalle C, <i>et al<\/i>. Contrast agents and renal cell apoptosis. Eur Heart J 2008; 29: 2569-76.","DOI":"10.1093\/eurheartj\/ehn197"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Iida O, Soga Y, Hirano K, <i>et al<\/i>. Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischemia due to isolated below-the knee lesions. Eur J Vasc Endovasc Surg 2012; 43: 313-21.","DOI":"10.1016\/j.ejvs.2011.11.025"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47: 975-81.","DOI":"10.1016\/j.jvs.2008.01.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-52.","DOI":"10.1016\/0002-9343(89)90437-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marenzi G, Marana I, Lauri G, <i>et al<\/i>. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-40.","DOI":"10.1056\/NEJMoa023204"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Spargias K, Alexopoulos E, Kyrzopoulos S, <i>et al<\/i>. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-42.","DOI":"10.1161\/01.CIR.0000146396.19081.73"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fung JW, Szeto CC, Chan WW, <i>et al<\/i>. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. Am J Kidney Dis 2004; 43: 801-8.","DOI":"10.1053\/j.ajkd.2004.01.010"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Spargias K, Adreanides E, Demerouti E, <i>et al<\/i>. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2009; 120: 1793-9.","DOI":"10.1161\/CIRCULATIONAHA.109.863159"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hafiz AM, Jan MF, Mori N, <i>et al<\/i>. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies. Catheter Cardiovasc Interv 2012; 79: 929-37.","DOI":"10.1002\/ccd.23148"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hu X, Zhuang XD, Li Y, <i>et al<\/i>. A nomogram to predict contrast induced nephropathy in patients undergoing percutaneous coronary intervention? Int Heart J 2017; 58: 191-6.","DOI":"10.1536\/ihj.16-213"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Palena LM, Diaz-Sandoval LJ, Candeo A, Brigato C, Sultato E, Manzi M. Automated carbon dioxide angiography for the evaluation and endovascular treatment of diabetic patients with critical limb ischemia. J Endovasc Ther 2016; 23: 40-8.","DOI":"10.1177\/1526602815616924"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Iranirad L, Hejazi SF, Sadeghi MS, Jang SA. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: a prospective randomized controlled trial. Cardiol J 2017; 24: 502-7.","DOI":"10.5603\/CJ.a2017.0028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lian D, Liu Y, Liu YH, Li HL, Duan CY, Yu DQ. Pre-procedural risk score of contrast-induced nephropathy in elderly patients undergoing elective coronary angiography. Int Heart J 2017; 58: 197-204.","DOI":"10.1536\/ihj.16-129"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Isenbarger DW, Kent SM, O&apos;Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003; 92: 1454-8.","DOI":"10.1016\/j.amjcard.2003.08.059"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Koide M, Kato M, Usui K, <i>et al<\/i>. Successful complete revascularization with PCI using super-low volume of contrast medium in a patient with three-vessel disease including 2 chronic total occlusions with severe renal dysfunction. Int Heart J 2017; 58: 624-8.","DOI":"10.1536\/ihj.16-442"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujihara M, Kawasaki D, Shintani Y, <i>et al<\/i>. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry. Catheter Cardiovasc Interv 2015; 85: 870-7.","DOI":"10.1002\/ccd.25722"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawasaki D, Fujii K, Fukunaga M, Masutani M, Nakata A, Masuyama T. Safety and efficacy of endovascular therapy with a simple homemade carbon dioxide delivery system in patients with ileofemoral artery disease. Circ J 2012; 76: 1722-8.","DOI":"10.1253\/circj.CJ-11-1382"},{"key":"18","unstructured":"18. Shikata H, Kobata T, Hida K, <i>et al<\/i>. Endovascular revascularization under carbon dioxide angiography. JJCVS 2005; 34: 237-42."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kawasaki D, Tsujino T, Fujii K, Masutani M, Ohyanagi M, Masuyama T. Novel use of ultrasound guidance for recanalization of iliac, femoral, and popliteal arteries. Catheter Cardiovasc Interv 2008; 71: 727-33.","DOI":"10.1002\/ccd.21503"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mariani J Jr, Guedes C, Soares P, <i>et al<\/i>. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utilization With IVUS Guidance in coronary angioplasty) randomized controlled trial. JACC Cardiovasc Interv 2014; 7: 1287-93.","DOI":"10.1016\/j.jcin.2014.05.024"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Joshi SB, Mendoza DD, Steinberg DH, <i>et al<\/i>. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. JACC Cardiovasc Imaging 2009; 2: 1404-11.","DOI":"10.1016\/j.jcmg.2009.08.010"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Anderson JL, Halperin JL, Albert NM, <i>et al<\/i>. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: 1425-43.","DOI":"10.1161\/CIR.0b013e31828b82aa"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_18-125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:51:35Z","timestamp":1548557495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/1\/60_18-125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.18-125","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]}}}